• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD44中硫酸乙酰肝素和硫酸软骨素组装位点的表征

Characterization of the heparan sulfate and chondroitin sulfate assembly sites in CD44.

作者信息

Greenfield B, Wang W C, Marquardt H, Piepkorn M, Wolff E A, Aruffo A, Bennett K L

机构信息

Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543, USA.

出版信息

J Biol Chem. 1999 Jan 22;274(4):2511-7. doi: 10.1074/jbc.274.4.2511.

DOI:10.1074/jbc.274.4.2511
PMID:9891022
Abstract

Isoforms of CD44 are differentially modified by the glycosaminoglycans (GAGs) chondroitin sulfate (CS), heparan sulfate (HS), and keratan sulfate. GAG assembly occurs at serines followed by glycines (SG), but not all SG are utilized. Seven SG motifs are distributed in five CD44 exons, and in this paper we identify the HS and CS assembly sites that are utilized in CD44. Not all the CD44 SG sites are modified. The SGSG motif in CD44 exon V3 is the only HS assembly site; this site is also modified with CS. HS and CS attachment at that site was eliminated by mutation of the serines in the V3 motif to alanine (AGAG). Exon E5 is the only other CD44 exon that supports GAG assembly and is modified with CS. Using a number of recombinant CD44 protein fragments we show herein that the eight amino acids located downstream of the SGSG site in V3 are responsible for the specific addition of HS to this site. If the eight amino acids located downstream from the first SG site in CD44 exon E5 are exchanged with those located downstream of the SGSG site in exon V3, the SG site in E5 becomes modified with HS and CS. Likewise if the eight amino acids found downstream from the first SG in E5 are placed downstream from the SGSG in V3, this site is modified with CS but not HS. We also show that these sequences cannot direct the modification of CD44 with HS from a distance. Constructs containing CD44 exon V3 in which the SGSG motif was mutated to AGAG were not modified with HS even though they contained other SG motifs. Thus, a number of sequence and structural requirements that dictate GAG synthesis on CD44 have been identified.

摘要

CD44的亚型被糖胺聚糖(GAGs)硫酸软骨素(CS)、硫酸乙酰肝素(HS)和硫酸角质素以不同方式修饰。GAG组装发生在丝氨酸之后紧跟甘氨酸(SG)的位点,但并非所有的SG位点都被利用。七个SG基序分布在五个CD44外显子中,在本文中我们确定了CD44中被利用的HS和CS组装位点。并非所有的CD44 SG位点都被修饰。CD44外显子V3中的SGSG基序是唯一的HS组装位点;该位点也被CS修饰。通过将V3基序中的丝氨酸突变为丙氨酸(AGAG),消除了该位点的HS和CS附着。外显子E5是CD44中另一个支持GAG组装并被CS修饰的外显子。我们在此使用多个重组CD44蛋白片段表明,V3中SGSG位点下游的八个氨基酸负责该位点HS的特异性添加。如果将CD44外显子E5中第一个SG位点下游的八个氨基酸与外显子V3中SGSG位点下游的那些氨基酸进行交换,E5中的SG位点就会被HS和CS修饰。同样,如果在E5中第一个SG下游发现的八个氨基酸置于V3中SGSG的下游,该位点会被CS修饰但不会被HS修饰。我们还表明,这些序列不能远距离指导CD44被HS修饰。含有将SGSG基序突变为AGAG的CD44外显子V3的构建体即使含有其他SG基序也不会被HS修饰。因此,已经确定了决定CD44上GAG合成的许多序列和结构要求。

相似文献

1
Characterization of the heparan sulfate and chondroitin sulfate assembly sites in CD44.CD44中硫酸乙酰肝素和硫酸软骨素组装位点的表征
J Biol Chem. 1999 Jan 22;274(4):2511-7. doi: 10.1074/jbc.274.4.2511.
2
Generation of artificial proteoglycans containing glycosaminoglycan-modified CD44. Demonstration of the interaction between rantes and chondroitin sulfate.含糖胺聚糖修饰的CD44的人工蛋白聚糖的生成。RANTES与硫酸软骨素之间相互作用的证明。
J Biol Chem. 1999 Jan 22;274(4):2518-24. doi: 10.1074/jbc.274.4.2518.
3
CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor.包含外显子V3的CD44亚型负责肝素结合生长因子的呈递。
J Cell Biol. 1995 Feb;128(4):687-98. doi: 10.1083/jcb.128.4.687.
4
Chondroitin sulphate composition and structure in alternatively spliced CD44 fusion proteins.可变剪接的CD44融合蛋白中的硫酸软骨素组成与结构
Biochem J. 1997 Oct 15;327 ( Pt 2)(Pt 2):499-506. doi: 10.1042/bj3270499.
5
Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44.一种大型硫酸软骨素/硫酸皮肤素蛋白聚糖(多功能蛋白聚糖)与L-选择素、P-选择素和CD44的结合。
J Biol Chem. 2000 Nov 10;275(45):35448-56. doi: 10.1074/jbc.M003387200.
6
Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.淋巴细胞归巢受体CD44的蛋白聚糖形式是包含v3外显子的可变剪接变体。
J Cell Biol. 1995 Feb;128(4):673-85. doi: 10.1083/jcb.128.4.673.
7
Mechanisms underlying preferential assembly of heparan sulfate on glypican-1.硫酸乙酰肝素在磷脂酰肌醇蛋白聚糖-1上优先组装的潜在机制。
J Biol Chem. 2001 Mar 9;276(10):7507-17. doi: 10.1074/jbc.M008283200. Epub 2000 Dec 5.
8
Characterization of ryudocan glycosaminoglycan acceptor sites.柳多糖糖胺聚糖受体位点的表征
J Biol Chem. 1994 Aug 19;269(33):21204-14.
9
Heparan sulfate composition of alternatively spliced CD44 fusion proteins.可变剪接的CD44融合蛋白的硫酸乙酰肝素组成
Biochem Biophys Res Commun. 1999 Apr 21;257(3):839-42. doi: 10.1006/bbrc.1999.0553.
10
Agrin is a chimeric proteoglycan with the attachment sites for heparan sulfate/chondroitin sulfate located in two multiple serine-glycine clusters.集聚蛋白是一种嵌合蛋白聚糖,其硫酸乙酰肝素/硫酸软骨素的附着位点位于两个多个丝氨酸 - 甘氨酸簇中。
J Biol Chem. 2003 Aug 8;278(32):30106-14. doi: 10.1074/jbc.M212676200. Epub 2003 May 28.

引用本文的文献

1
CD44 in Bone Metastasis Development: A Key Player in the Fate Decisions of the Invading Cells?CD44 在骨转移发展中的作用:入侵细胞命运抉择的关键因素?
Clin Exp Metastasis. 2023 Apr;40(2):125-135. doi: 10.1007/s10585-023-10203-z. Epub 2023 Apr 10.
2
CD44 Glycosylation as a Therapeutic Target in Oncology.CD44糖基化作为肿瘤治疗靶点
Front Oncol. 2022 Jul 21;12:883831. doi: 10.3389/fonc.2022.883831. eCollection 2022.
3
Polysaccharide-Polyplex Nanofilm Coatings Enhance Nanoneedle-Based Gene Delivery and Transfection Efficiency.
多糖-多聚物纳米纤维膜涂层可提高基于纳米针的基因传递和转染效率。
Small. 2022 Sep;18(36):e2202303. doi: 10.1002/smll.202202303. Epub 2022 Jun 30.
4
CD44-Targeted Nanocarrier for Cancer Therapy.用于癌症治疗的CD44靶向纳米载体。
Front Pharmacol. 2022 Mar 31;12:800481. doi: 10.3389/fphar.2021.800481. eCollection 2021.
5
CD44 in Ovarian Cancer Progression and Therapy Resistance-A Critical Role for STAT3.CD44在卵巢癌进展和治疗耐药中的作用——STAT3的关键作用
Front Oncol. 2020 Dec 1;10:589601. doi: 10.3389/fonc.2020.589601. eCollection 2020.
6
CD44 as a tumor biomarker and therapeutic target.CD44作为一种肿瘤生物标志物和治疗靶点。
Exp Hematol Oncol. 2020 Dec 10;9(1):36. doi: 10.1186/s40164-020-00192-0.
7
A defucosylated anti‑CD44 monoclonal antibody 5‑mG2a‑f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma.一种去岩藻糖基化抗 CD44 单克隆抗体 5-mG2a-f 在口腔鳞状细胞癌的小鼠异种移植模型中发挥抗肿瘤作用。
Oncol Rep. 2020 Nov;44(5):1949-1960. doi: 10.3892/or.2020.7735. Epub 2020 Aug 14.
8
The Role of Proteoglycans in Cancer Metastasis and Circulating Tumor Cell Analysis.蛋白聚糖在癌症转移和循环肿瘤细胞分析中的作用
Front Cell Dev Biol. 2020 Aug 26;8:749. doi: 10.3389/fcell.2020.00749. eCollection 2020.
9
A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Patients with Bladder Cancer.一种新型 HYAL-4 剪接变体驱动膀胱癌恶性转化并预测患者预后。
Clin Cancer Res. 2020 Jul 1;26(13):3455-3467. doi: 10.1158/1078-0432.CCR-19-2912. Epub 2020 Feb 24.
10
Structural Characterization of the CD44 Stem Region for Standard and Cancer-Associated Isoforms.CD44 干细胞区结构特征的标准和癌症相关亚型。
Int J Mol Sci. 2020 Jan 3;21(1):336. doi: 10.3390/ijms21010336.